Andrea Agathoklis Murino

Andrea Agathoklis Murino

Partner Co-Chair, Washington D.C.
Andrea Agathoklis Murino

Andrea Agathoklis Murino is a Chambers-ranked partner in and co-chair of Goodwin’s Antitrust & Competition Law practice, co-chair of the firm's Washington D.C. office, leader of its Specialty Litigation group, and a member of the firm’s Executive Committee. Ms. Murino’s unique combination of private and public sector experience allow her to provide practical, bespoke, and efficient pathways to achieving her clients’ business objectives. Her primary focus is securing clearances for proposed transactions from the Antitrust Division of the U.S. Department of Justice, the U.S. Federal Trade Commission, state attorneys general, and international competition law enforcement agencies. In the past year alone, she has successfully represented more than 100 clients through all manner of transaction-related investigations, including several high-profile Second Requests and dozens of intensive public and non-public investigations. Ms. Murino also has significant merger litigation experience, having served as senior member of a trial team that defended a rare consummated merger challenge in federal court. Furthermore, she regularly advises on numerous other competition issues, including dominant firm conduct, competitor collaborations, and distribution practices. Ms. Murino’s practice also includes representing clients on consumer protection matters before the FTC and state attorneys general, including claims of false advertising and deceptive marketing practices. Among her clients are companies in the healthcare, pharmaceuticals, technology, financial services, telecommunications, medical devices, consumer products, hospitality, real estate, and retail industries.

Ms. Murino served the highest decision-makers at both federal antitrust enforcement agencies. She was an attorney advisor to former FTC Chairman and Commissioner William Kovacic where she offered advice on a diverse array of competition and consumer protection matters. She then served as a counsel to two Assistant Attorneys General for Antitrust at the Department of Justice where she advised the Assistant Attorney General and the Deputy Assistant Attorneys General on criminal and civil enforcement matters. She joined Goodwin after having been a partner with Wilson Sonsini Goodrich & Rosati and spent the earlier part of her career as an associate with Freshfields Bruckhaus Deringer.

Ms. Murino is recognized in the Washington, DC Antitrust & Competition category in Chambers USA: America’s Leading Lawyers for Business, where clients praised her for being “super responsive, very practical and a creative problem solver,” while also noting “she is a real pleasure to work with.” She is a recommended lawyer by The Legal 500 United States, where she is described in client testimonials as a very strong and persuasive communicator” who can “distill down the primary advocacy arguments in a case and communicate those ideas persuasively to the antitrust agencies.” Ms. Murino was also named to Who's Who Legal Competition 2020 where she was lauded for her “superb client management skills,” “pragmatic approach,” and described as an “excellent communicator.” Additional acknowledgements include being named to The National Law Journal’s 2018 M&A and Antitrust Trailblazers list, an award that recognizes lawyers who continue to make their mark in various aspects of deal making and strategic planning, Global Competition Review’s Women in Antitrust list, which recognizes women at the helm of law firms' competition practices, and the 2016 Global Competition Review 40 Under 40 list.

A frequent speaker, Ms. Murino spoke at the FTC’s Hearings on Competition and Consumer Protection in the 21st Century addressing multi-sided platforms, labor markets, and potential competition. She has also participated in international events, including speaking at the Mexican Federal Economic Competition Commission’s (COFECE’s) workshop on Antitrust, Innovation, and Entrepreneurship, and at meetings of the International Competition Network. Ms. Murino has been a member of Law360’s Competition Law Editorial Advisory Board since 2016 and serves on the MLex Advisory Board, where she consults and advises on significant developments impacting antitrust and competition law. Ms. Murino is an Associate Editor of Antitrust, a quarterly magazine devoted to global antitrust and competition related topics, and also contributes to the “Antitrust Practice Advisor” for LexisNexis, which offers a collection of practical guidance written by attorneys for their practice areas.

Areas of Practice
Domaines D’Expertise





Below is a partial list of the publicly announced in-depth investigations and Second Requests where Ms. Murino and her team provided advice to clients before the FTC and DOJ:

  • Albany Medical Center, the largest locally-governed health system in the New York Capital-region, in its acquisition of Glens Falls Hospital, which, upon closing, will create one of the largest health systems providing care to residents throughout Northeastern New York state. Both the FTC and Attorney General of the State of New York examined this transaction, ultimately clearing it without condition.
  • Spark Therapeutics in its +$4b sale to Roche. Following an extensive and intensive 10-month investigation focused around novel gene therapy treatments for Hemophilia A, this transaction was cleared without condition by the Federal Trade Commission on a 5-0 vote. The Competition Markets Authority in the United Kingdom similarly cleared the transaction following its own investigation

Since January 1, 2017, Ms. Murino and her team have represented clients successfully in the following in-depth investigations (Second Requests) before the FTC and DOJ:

  • Beth Israel Deaconess Medical Center, Lahey Health System, New England Baptist Hospital, Mount Auburn Hospital, and Seacoast Regional Health System in their $5+ billion merger to create Beth Israel Lahey Health, the second largest healthcare system in the Eastern Massachusetts area. Approvals were required from both the FTC and multiple state-level agencies, including the Office of the Attorney General of Massachusetts. The Boston Globe described the combination as “the most significant health care deal in Massachusetts” in decades.
  • Rainmaker in its $300 million sale of its LRO software and related assets to RealPage. After concluding compliance with a Second Request process, this transaction was cleared by the DOJ without condition.
  • Concert Pharmaceuticals in the $250 million sale of its cystic fibrosis drug to Vertex Pharmaceuticals. The FTC issued a Second Request in this transaction that combined two makers of a certain cystic fibrosis treatments. By using novel strategies to minimize the scope of the Second Request and therefore speed the FTC review process, we achieved unconditional clearance in unprecedented time of less than 6 weeks.
  • SGL Group of Germany in the $400 million sale of its worldwide graphite electrode business to Showa Denko KK of Japan. Following compliance with a Second Request from the DOJ, this transaction was cleared.

Ms. Murino’s work in assuring antitrust clearance in publicly announced transactions which were required to be reported under the HSR Act include:

  • Truck Hero International, a leading automotive accessories provider, in its acquisition of Lund International, another leading automotive accessories provider
  • Brammer Bio in Its $1.7 Billion Sale to Thermo Fisher Scientific
  • Ipsen in its $1.3 billion acquisition of Clementia Pharmaceuticals
  • Twilio in its $3b acquisition of SendGrid
  • TurnItIn in its $1.75b sale to Advance Publications
  • The Independent Directors of Sprint Corporation in their $59 billion merger with T-Mobile USA
  • PillPack, Inc. in its $1 billion acquisition by Amazon
  • Control4 in its $680 million sale to SnapAV
  • Qualtrics in its $8 billion acquisition by SAP SE
  • Marc and Lynne Benioff in their acquisition of TIME Media from Meredith Corporation
  • Thoma Bravo, LLC in its acquisition of motus, LLC and Runzheimer International LLC
  • hyperWALLET Systems, Inc. in its $400 million acquisition by PayPal in the United States
  • Teva Pharmaceuticals in its $2 billion sale of its women’s health business
  • Amplify Snack Brands, Inc. in its sale to The Hershey Company for $1.6 billion. 
  • Kind, Inc. (makers of Kind bars) in its $4 billion investment from Mars, Inc.
  • Eventbrite's in its $200 million purchase of Ticketfly
  • Lennar Corporation in its $9.3 billion acquisition of CalAtlantic Group, creating the United States’ largest homebuilder 
  • Onyx Pharmaceuticals in its $10.4 billion acquisition by Amgen
  • Wirtgen Group in its $5 billion sale to John Deere & Company
  • Parexel in its $5 billion sale to Pamploma Capital
  •, Inc. in its $1.5 billion acquisition by LinkedIn Corporation
  • Partners Group in its $1.5 billion acquisition of Knowledge Universe Education
  • Xoom Corporation in its $890 million acquisition by eBay
  • Moovit, the maker of an app that provides direction based on real-time traffic data, in its $900 million acquisition by Intel

Other notable work for clients outside the HSR context includes:

  • Providing antitrust counsel and guidance to multiple healthcare providers and healthcare systems across the United States seeking to expand their networks in proceedings before the federal antitrust authorities, their relevant state regulatory bodies, and state attorneys general.
  • Successfully representing multiple third parties in the federal district court proceedings related to the FTC and DOJ merger challenges
  • Providing ongoing, confidential guidance to three leading international investment advisors regarding risks of antitrust enforcement and potential remedies in connection with multi-billion dollar transactions.
  • Representing Beth Israel Deaconess Medical Center, Atrius Health, Lahey Health, and Tufts University Medical Center in successfully blocking a nonprofit health organization's acquisition of South Shore Hospital Corporation and Hallmark Health. This was the first time a state court rejected a proposed antitrust settlement between the Massachusetts Attorney General's Office and private entities.
Professional Experience

Ms. Murino is a member of the District of Columbia Bar Association, the American Bar Association (ABA), and the American Health Lawyers Association (AHLA). She is active in the ABA’s Section of Antitrust Law, presently serving as an editor of Antitrust Magazine. She was previously chair of the Programs and Teleseminars Committee, where she helped oversee the planning of 8-9 conferences per year related to various antitrust topics. She served as vice chair of the 2014 Clayton Act at 100 Symposium, the 2013 Fall Forum, the 2013 Merger Retrospective Symposium, and the 2012 Presidential Transition Report Task Force. As a member of the AHLA, she has led webinars to educate lawyers on developments at the intersection of healthcare and antitrust law.

In addition to her professional associations, Ms. Murino is involved in numerous community and philanthropic organizations. She presently serves on the Board of Directors of Elizabeth Seton High School in Prince George's County, Maryland, and was formerly a member of the Board of StrongMinds Africa, a non-profit organization seeking to empower impoverished African women by treating depression through innovative group therapy programs, and her undergraduate and graduate school alumni boards.

In The News









J.D., 2001
The George Washington University Law School

(With Honors)

B.A., 1998
American University, Economics and Political Science

(magna cum laude, Phi Beta Kappa, University Honors Program)



District of Columbia
New York


U.S. District Court for the District of Columbia
U.S. Supreme Court
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique